BSE filing, NSE: SYMPHONY. Summary written from the filing by ALFA Finder's alert engine.
Symphony Ltd: key numbers
- Share price
- ₹500.00
- Market cap
- ₹3,434 Cr
- Revenue (annual)
- ₹1,130 Cr
- Net profit (annual)
- ₹-141.1 Cr
- P/E (TTM)
- -24.7×Sector 41.7×
- Promoter holding
- 73.43%+0.00% QoQ
- FII holding
- 2.20%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Symphony Ltd
All →Symphony Dividend
Symphony fixed November 4, 2026 as record date for 2nd Interim Dividend FY 2026-27, subject to Board approval. No per-share amount disclosed.
Symphony Board Meeting Date
Symphony intimated a Board Meeting for October 29, 2026, to consider Q2/H1 results and a potential 2nd interim dividend. No amounts are specified in this advance notice.
Symphony Other Announcement
Symphony Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026, as per regulatory requirements.
Symphony Other Announcement
Symphony Ltd notified exchanges that its CMD will interact with India TV on 9 Sep 2026 to discuss the business overview. No new information or business substance is disclosed beyond the media schedule.
Symphony Promoter Selling (Off-Market)
Founder Promoter Achal Anil Bakeri will gift 3.43 lakh shares, representing 0.5% stake, to employees and their relatives. The transfer is a non-monetary gift over four years.
- Execution
- 4 years
Symphony Product Launch
Symphony Limited plans to expand its product portfolio by entering the Room Air Conditioners, BLDC Ceiling Fans, and Air Purifiers segments starting from December 2026.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.